Your account is not claimed yet. You can sign up with ORCID to claim your account.

Marjolein C Stip

Years Active: 2022-2023
Publications (10 Years): 4

This page only lists publications with an associated author ORCID identifier.

Publications

Marjolein C Stip, Mitchell Evers, Maaike Nederend, Chilam Chan, Karli R Reiding, Mirjam J Damen, Albert J R Heck, Sofia Koustoulidou, Ruud Ramakers, Gerard C Krijger, Remmert de Roos, Edouard Souteyrand, Annelisa M Cornel, Miranda P Dierselhuis, Marco Jansen, Mark de Boer, Thomas Valerius, Geert van Tetering, Jeanette H W Leusen, Friederike Meyer-Wentrup
IgA antibody immunotherapy targeting GD2 is effective in preclinical neuroblastoma models. Journal for immunotherapy of cancer 11 (7) (2023)
Marjolein C Stip, J H Marco Jansen, Maaike Nederend, Maria Tsioumpekou, Mitchell Evers, Patricia A Olofsen, Friederike Meyer-Wentrup, Jeanette H W Leusen
Characterization of human Fc alpha receptor transgenic mice: comparison of CD89 expression and antibody-dependent tumor killing between mouse strains. Cancer immunology, immunotherapy : CII (2023)
Patricia A Olofsen, Marjolein C Stip, J H Marco Jansen, Chilam Chan, Maaike Nederend, Ralph G Tieland, Maria Tsioumpekou, Jeanette H W Leusen
Effective, Long-Term, Neutrophil Depletion Using a Murinized Anti-Ly-6G 1A8 Antibody. Cells 11 (21) (2022)
Danique E M Duits, Camilla Salvagno, Elisabeth A M Raeven, Kim Vrijland, Marjolein C Stip, Cheei-Sing Hau, Daphne Kaldenbach, Karin E de Visser
hMRP8-ATTAC Mice: A New Model for Conditional and Reversible Neutrophil Ablation. Cells 11 (15) (2022)

Marjolein C Stip.css-eqlu8i{font-size:small;padding-left:4px;}